Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation
- 30 June 2017
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 9 (28) , 10020-10030
Abstract
Here we have developed a novel approach where two synergistically acting drugs were completely inactivated upon chemical immobilization on a nanoparticle template and activated in response to a chemical stimulus. The activation rate of each drug payload is controlled using a biologically inert bioorthogonal chemistry approach. By exploiting the subtle differences in the ‘click-to-release’ bioorthogonal reaction, we engineered a single delivery platform capable of releasing the payloads in a time-staggered manner in response to a single dose of a highly specific, yet reactive, small molecule. Incorporation of both di-axial, ‘fast release’, and di-equatorial, ‘slow release’, TCO linkers into our nanodrug assembly inhibited the activity of the drug molecules and enabled us to control the timing and activation of each payload. This single-trigger dual-responsive nanoparticle construct and its release kinetics were characterized using two molecular fluorescent probes and tested in vitro for efficient delivery of molecular payloads. In this manuscript we show that this approach was also successful in the treatment of triple negative BT-20 breast cancer cells. Our nanodrug loaded with the slow-releasing doxorubicin and fast-releasing PAC-1 prodrugs displayed a greater therapeutic response than the nanodrug which released both payloads simultaneously.Keywords
This publication has 51 references indexed in Scilit:
- Using Temperature-Sensitive Smart Polymers to Regulate DNA-Mediated Nanoassembly and Encoded Nanocarrier Drug ReleaseACS Nano, 2013
- Profiling the Substrate Specificity of Protein Kinases by On-Bead Screening of Peptide LibrariesBiochemistry, 2013
- An Exceptionally Simple Strategy for DNA-Functionalized Up-Conversion Nanoparticles as Biocompatible Agents for Nanoassembly, DNA Delivery, and ImagingJournal of the American Chemical Society, 2013
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling NetworksCell, 2012
- MicroRNA Conjugated Gold Nanoparticles and Cell TransfectionAnalytical Chemistry, 2011
- Synthesis and Evaluation of a Series of 1,2,4,5-Tetrazines for Bioorthogonal ConjugationBioconjugate Chemistry, 2011
- Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detectionNature Nanotechnology, 2010
- Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugatesAdvanced Drug Delivery Reviews, 2010
- Tetrazine Ligation: Fast Bioconjugation Based on Inverse-Electron-Demand Diels−Alder ReactivityJournal of the American Chemical Society, 2008
- Systems biology and combination therapy in the quest for clinical efficacyNature Chemical Biology, 2006